80 related articles for article (PubMed ID: 7605229)
1. [Lipoprotein (a), apolipoproteins and the lipid profile late after heart transplantation].
Maranhão R; Santos RD; Furlaneto C; Graziosi P; Stolf N; Vinagre C; Bocchi E; Belotti G; Jatene A; Pileggi F
Arq Bras Cardiol; 1994 Dec; 63(6):465-8. PubMed ID: 7605229
[TBL] [Abstract][Full Text] [Related]
2. Lipoprotein(a) levels are increased in healthy young subjects with parental history of premature myocardial infarction.
Gaeta G; Cuomo S; Capozzi G; Foglia MC; Barra S; Madrid A; Stornaiuolo V; Trevisan M
Nutr Metab Cardiovasc Dis; 2008 Sep; 18(7):492-6. PubMed ID: 17962002
[TBL] [Abstract][Full Text] [Related]
3. Metabolic factors clustering, lipoprotein cholesterol, apolipoprotein B, lipoprotein (a) and apolipoprotein E phenotypes in premature coronary artery disease in French Canadians.
Weber M; McNicoll S; Marcil M; Connelly P; Lussier-Cacan S; Davignon J; Latour Y; Genest J
Can J Cardiol; 1997 Mar; 13(3):253-60. PubMed ID: 9117913
[TBL] [Abstract][Full Text] [Related]
4. Effect of dialysis type on serum lipids, apolipoproteins, and lipoproteins.
Kanbay M; Delibasi T; Kaya A; Aydogan T; Koca C; Akcay A; Duranay M; Yigitoglu R
Ren Fail; 2006; 28(7):567-71. PubMed ID: 17050239
[TBL] [Abstract][Full Text] [Related]
5. The nature of acute rejection is associated with development of graft vascular disease after clinical heart transplantation.
Baan CC; Holweg CT; Niesters HG; van Gelder T; Mol WM; Zondervan PE; Mochtar B; Balk AH; Weimar W
J Heart Lung Transplant; 1998 Apr; 17(4):363-73. PubMed ID: 9588581
[TBL] [Abstract][Full Text] [Related]
6. [Lipoprotein (a) and ischemic heart diseases in patients with type 2 diabetes].
Ben Hamda K; Masmoudi AS; Mandhouj O; Hammami S; Attia N; Smaoui M; Zidi MA; Nabli N; Chaaba R; Mahjoub S; Ben Farhat M; Hammami M
Arch Inst Pasteur Tunis; 2002; 79(1-4):27-33. PubMed ID: 15072242
[TBL] [Abstract][Full Text] [Related]
7. Elevated lipoprotein (a) and apolipoprotein B to AI ratio in South Asian patients with ischaemic stroke.
Sharobeem KM; Patel JV; Ritch AE; Lip GY; Gill PS; Hughes EA
Int J Clin Pract; 2007 Nov; 61(11):1824-8. PubMed ID: 17935546
[TBL] [Abstract][Full Text] [Related]
8. Reference values of plasma apolipoproteins A-I and B, and association with nonlipid risk factors in the populations of two Canadian provinces: Quebec and Saskatchewan. Canadian Heart Health Surveys Research Group.
Connelly PW; Poapst M; Davignon J; Lussier-Cacan S; Reeder B; Lessard R; Hegele RA; Csima A
Can J Cardiol; 1999 Apr; 15(4):409-18. PubMed ID: 10322250
[TBL] [Abstract][Full Text] [Related]
9. Aggressive lowering of fibrinogen and cholesterol in the prevention of graft vessel disease after heart transplantation.
Jaeger BR; Meiser B; Nagel D; Uberfuhr P; Thiery J; Brandl U; Brückner W; von Scheidt W; Kreuzer E; Steinbeck G; Reichart B; Seidel D
Circulation; 1997 Nov; 96(9 Suppl):II-154-8. PubMed ID: 9386091
[TBL] [Abstract][Full Text] [Related]
10. High lipoprotein(a) in children from kindreds with parental premature myocardial infarction.
Marquez A; Mendoza S; Carrasco H; Hamer T; Glueck CJ
Pediatr Res; 1993 Nov; 34(5):670-4. PubMed ID: 8284108
[TBL] [Abstract][Full Text] [Related]
11. Is increased apolipoprotein B-A major factor enhancing the risk of coronary artery disease in type 2 diabetes?
Snehalatha C; Ramachandran A; Sivasankari S; Satyavani K; Viswanathan V; Misra J; Girinath MR; Sathyamurthy I
J Assoc Physicians India; 2002 Aug; 50():1036-8. PubMed ID: 12421026
[TBL] [Abstract][Full Text] [Related]
12. The ratio of apoB/apoAI, apoB and lipoprotein(a) are the best predictors of stable coronary artery disease.
Rasouli M; Kiasari AM; Mokhberi V
Clin Chem Lab Med; 2006; 44(8):1015-21. PubMed ID: 16879071
[TBL] [Abstract][Full Text] [Related]
13. Conventional lipid profile and lipoprotein(a) concentrations in treated patients with rheumatoid arthritis.
García-Gómez C; Nolla JM; Valverde J; Gómez-Gerique JA; Castro MJ; Pintó X
J Rheumatol; 2009 Jul; 36(7):1365-70. PubMed ID: 19369465
[TBL] [Abstract][Full Text] [Related]
14. Apolipoprotein modifying effects of statins and fibrate in various age groups of coronary artery disease patients.
Sharma R; Mahajan M; Singh B; Bal BS; Kant R
J Indian Med Assoc; 2006 Sep; 104(9):492-4, 496, 498. PubMed ID: 17388006
[TBL] [Abstract][Full Text] [Related]
15. Serum levels of lipids and lipoproteins in Syrian patients with beta-thalassemia major.
Al-Quobaili FA; Abou Asali IE
Saudi Med J; 2004 Jul; 25(7):871-5. PubMed ID: 15235691
[TBL] [Abstract][Full Text] [Related]
16. Atherogenic profile in preeclampsia.
Var A; Kuşcu NK; Koyuncu F; Uyanik BS; Onur E; Yildirim Y; Oruç S
Arch Gynecol Obstet; 2003 Apr; 268(1):45-7. PubMed ID: 12673475
[TBL] [Abstract][Full Text] [Related]
17. Lipid Pentad Index: A novel bioindex for evaluation of lipid risk factors for atherosclerosis in young adolescents and children of premature coronary artery disease patients in India.
Das B; Daga MK; Gupta SK
Clin Biochem; 2007 Jan; 40(1-2):18-24. PubMed ID: 17052698
[TBL] [Abstract][Full Text] [Related]
18. Lipids and lipoprotein(a) as risk factors for vascular disease in patients on renal replacement therapy.
Webb AT; Reaveley DA; O'Donnell M; O'Connor B; Seed M; Brown EA
Nephrol Dial Transplant; 1995; 10(3):354-7. PubMed ID: 7792030
[TBL] [Abstract][Full Text] [Related]
19. Is an elevated level of serum lipoprotein (a) a risk factor for cardiovascular disease in CAPD patients?
Avram MM; Sreedhara R; Patel N; Chattopadhyay J; Thu T; Fein P
Adv Perit Dial; 1996; 12():266-71. PubMed ID: 8865917
[TBL] [Abstract][Full Text] [Related]
20. Potential atherogenic roles of lipids, lipoprotein(a) and lipid peroxidation in preeclampsia.
Bayhan G; Koçyigit Y; Atamer A; Atamer Y; Akkus Z
Gynecol Endocrinol; 2005 Jul; 21(1):1-6. PubMed ID: 16048794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
